In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $105.00 price target on Stryker Corporation SYK.
In the report, Morgan Stanley noted, "Our discussions with management at AAOS struck a bullish tone and pointed to an inflection coming over the next 12 months. We see opportunities to (i) gain share in Europe, specifically in MedSurg, (ii) drive Mako adoption following recent momentum and approvals, (iii) grow sports med and extremities through recent product additions,and (iv) build on emerging market progress through Trauson geographic expansion. Additionally, Stryker's balance sheet remains a flexible growth driver even as the SNN debate fades."
Stryker Corporation closed on Thursday at $91.53.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in